To explore this mechanism, we selected PV-1, a tumor endothelial cell-specific marker, along with Caveolin-1, which is known to facilitate albumin endocytosis by endothelial cells [23], and SPARC, a protein that specifically binds to albumin. The gene discussed is SPARC; the disease is neoplasm.